Cancer Molecular Diagnostics
| Full details for "RQ BCR::ABL1 p190". | |
|---|---|
Name |
RQ BCR::ABL1 p190 |
Alternative name/Profile |
MRD testing for BCR::ABL1 (p190) in Acute Lymphoblastic Leukaemia |
Department |
Cancer Molecular Diagnostics |
Investigation |
Detection and monitoring of BCR::ABL p190 variant in Chronic Myeloid Leukaemia and Acute Lymphoblastic Leukaemia |
Specimen type |
Peripheral Blood |
Sample type |
|
Sample container & volume |
9ml in EDTA (purple top) tube |
Frequency of analysis |
Weekly |
Turnaround time |
10-15 working days |
Availability |
Monday-Friday 9.30am to 5.00pm |
Notes |
For real-time quantitative PCR (RQ-PCR) of BCR::ABL1 in patients receiving tyrosine kinase inhibitor therapy, peripheral blood samples are preferable. Samples for molecular testing should arrive in the laboratory as soon as possible post collection. Samples should be refrigerated at 4°C until dispatch. |
Related links |
|
Reference range |
|
Last updated |
Tue, 17 Feb 2026 07:59:26 GMT |